Green ZebrasS.A.
Research and experimental development in natural sciences and engineering
Overview
Green Zebras is a technology company that develops formulations for functional food and active substance feed additives, leveraging its experience in human food products for the veterinary sector. The company is currently expanding its research and development activities in pharmaceutical veterinary medicine, seeking new candidates for companion animal medications. Their team collaborates with specialists in human and veterinary drug development, preclinical pharmacology, and in vivo studies.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 9.70
- High
- PLN 9.70
- Low
- PLN 9.70
- Volume
- 2
- Avg. vol.
- 140.1
- Market cap
- PLN 15.39M
- P/E ratio
- —
- EPS
- -PLN 1.33
- Shares outstanding
- 1.59M
- 52-week
- PLN 8.95 – 9.90
- Dividend yield
- —
- Dividend
- —
- Ex dividend date
- —
- ISIN
- PLGRNZB00015
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 4.86k | USD -201.78k | USD -202.05k |
| Q1 2026 | USD 80.23k | USD -111.02k | USD -113.72k |
| Q4 2025 | USD 67.30k | USD -126.82k | USD -128.83k |
| Q3 2025 | USD 77.10k | USD -109.49k | USD -108.99k |
Results for Q3 2026:Nov 13, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-04-23. Active
48 1090 2590 0000 0001 6616 4401- 96 1090 2590 0000 0001 6616 4119
04 2490 0005 0000 4530 3300 5812
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 11, 2023 | Commercial Companies Code notice | |
| Nov 10, 2023 | Bankruptcy notice | |
| Oct 18, 2023 | Shareholders' meeting convened |
Public aid
7 public aid cases recorded, with a total value of $45,106.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 26, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | — | Marszałek Województwa Dolnośląskiego | |
| Aug 6, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | — | Dolnośląska Agencja Współpracy Gospodarczej sp. z o.o. | |
| Sep 29, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | — | Prezydent Wrocławia |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The company is represented by each member of the management board independently.
Supervisory board
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Freshmazovia Consultingsp. z o.o. | $1,625,635.33 | freshmazoviaconsulting.pl | |
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | |
| Ecoverseasp. z o.o. | $891,022.45 | coslab.pl | |
| BioceltixS.A. | $616,315.97 | bioceltix.com | |
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | |
| VET Cell Techsp. z o.o. | $483,439.81 | vetcelltech.com | |
| MedisensonicS.A. | $362,572.63 | medisensonic.com | |
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | |
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | |
| Countess Laboratoriessp. z o.o. | $99,221.13 | countess.pl |
Change history
| Date | Event |
|---|---|
| 2026-09-02 | Share capital change (158,656.80 PLN → 165,781.80 PLN) |
| 2025-11-21 | Share capital change (132,781.80 PLN → 158,656.80 PLN) |
| 2024-12-24 | PKD change (Removed: 01.28.Z, 20.42.Z, 71.20.B; Added: 10.91.Z, 10.92.Z, 21.20.Z) |
| 2024-02-02 | Share capital change (124,816.90 PLN → 132,781.80 PLN) |
| 2023-10-09 | Share capital change (120,930.00 PLN → 124,816.90 PLN) |
FAQ
Last updated: 2026-09-02